1. 1. Behar-Cohen, F. F., Savoldelli, M., Parel, J. M., Goureau, O., Thillaye-Goldenberg, B., Courtois, Y., Pouliquen, Y. and de Kozak, Y. 1998. Reduction of corneal edema in endotoxin-induced uveitis after application of L-NAME as nitric oxide synthase inhibitor in rats by iontophoresis. Invest. Ophthalmol. Vis. Sci. 39: 897–904.
2. 2. Bellot, J. L., Palmero, M., García-Cabanes, C., Espí, R., Hariton, C. and Orts, A. 1996. Additive effect of nitric oxide and prostaglandin-E2 synthesis inhibitors in endotoxin-induced uveitis in the rabbit. Inflamm. Res. 45: 203–208.
3. 3. Brito, B. E., O’Rourke, L. M., Pan, Y., Anglin, J., Planck, S. R. and Rosenbaum, J. T. 1999. IL-1 and TNF receptor-deficient mice show decreased inflammation in an immune complex model of uveitis. Invest. Ophthalmol. Vis. Sci. 40: 2583–2589.
4. 4. Chan, C. C., Tuaillon, N., Li, Q. and Shen, D. F. 2000. Therapeutic applications of antiflammin peptides in experimental ocular inflammation. Ann. N. Y. Acad. Sci. 923: 141–146.
5. 5. Chen, C. Y., Peng, W. H., Tsai, K. D. and Hsu, S. L. 2007. Luteolin suppresses inflammation-associated gene expression by blocking NF-kappaB and AP-1 activation pathway in mouse alveolar macrophages. Life Sci. 81: 1602–1614.